XINDE MARINE NEWS
Antigua and Barbuda and the United Arab Emirates accept 2021 IMO Convention amendments IMO 2023-03-15 10:30

Antigua and Barbuda and the United Arab Emirates have become the latest IMO Member States to accept amendments to the Convention on the International Maritime Organization, which will expand the size of the Council, extend the term of its Members, and recognize three additional language texts as authentic versions of the Convention.

IMO Secretary-General Kitack Lim welcomed H.E. Ambassador Dwight Gardiner OBE, Permanent Representative of Antigua and Barbuda to IMO and H.E. Khalid Saud AlQasimi, Deputy Head of Mission of the United Arab Emirates at IMO HQ, London (14 March) to receive the instruments of acceptance.
 
The amendments have now been accepted by eleven States: Antigua and Barbuda, Canada, Honduras, Malaysia, Malta, the Kingdom of the Netherlands, Norway, Singapore, Spain, Thailand, and the United Arab Emirates. The amendments were adopted at the 32nd session of the IMO Assembly held in December 2021. They require acceptance by two thirds of the IMO Membership (117 Member States based on the current number of 175 Member States) for entry into force.

Source: IMO

The opinions expressed herein are the author's and not necessarily those of The Xinde Marine News.

Please Contact Us at:

media@xindemarine.com


 

展开全文

Related Posts

SMDERI-QET achieves world’s first ship-to-ship LCO₂ transfer

Blue-C2025-06-27

ICS and European Shipowners | ECSA welcome the Hong Kong Convention entering into force globally

ICS2025-06-26

Towngas signs green methanol MOUs with parties including TLB to support Hong Kong’s development as

The Hong Kong and China Gas Co2025-06-26

KR Teams Up with Leading Shipbuilders and Korea Testing & Research Institute to Develop Internati

Navigate PR2025-06-20

New ICS Chairman Designate named and Secretary General takes the helm as industry faces critical glob

ICS2025-06-16

GCMD launches report "Path to Zero-Carbon Shipping – Insights from ammonia transfer trial in t

GCMD2025-06-13